Redmile Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
Other funds holding GWPH
PCM
HI
FCM
GCL
EMG
AAM
UOC
Redmile Group's GWPH Position: Q1 2021 in Review
Redmile Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 815,681 shares — an estimated $94.1M sold.
Redmile Group first reported a position in GWPH in Q3 2013 and held it in 14 quarters. The position peaked at $94.1M in Q4 2020. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.
- Redmile Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
- Redmile Group sold 815,681 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $94.1M.
- Redmile Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2013 and held it in 14 quarters.
- Redmile Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $94.1M in Q4 2020.
- 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.
Based on Redmile Group's 13F filing for Q1 2021, filed 17 May 2021.